该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-24,总裁, Cambrex Profarmaco,RUSSOLO PAOLO ,期权,22000普通股, $4.40
$凯姆布雷克斯(CBM)$ 美东时间 2013-06-03 15:00 Cambrex at Jefferies Global Healthcare Conference
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-16,Director,HENDRIX LEON J JR ,卖出,1120普通股, $13.40
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-16,Director,HENDRIX LEON J JR ,期权,2000普通股, $7.39
$凯姆布雷克斯(CBM)$ 美东时间 2013-05-20 13:00 Cambrex at UBS Global Healthcare Conference
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-08,Director,KORB WILLIAM B ,卖出,2000普通股, $12.42
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-08,Director,KORB WILLIAM B ,期权,2000普通股, $7.39
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-07,Director,DIXON ROSINA B ,期权,2000普通股, $7.39
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-07,Director,MILLER JOHN R ,卖出,2000普通股, $12.36
内部交易: $凯姆布雷克斯(CBM)$ 2013-05-07,Director,MILLER JOHN R ,期权,2000普通股, $7.39